99.8% HPLC Verified

Endotoxin levels strictly maintained below 0.6ng/. Zero protein aggregation via 150kDa filtration.

48-Hour Rapid Onset

80% wrinkle reduction at Day 7 (P<0.01). Stable therapeutic effect maintained for 16-24 weeks.

1:3 Precision Ratio

Low-diffusion formulation minimizes migration risk to non-target muscles (e.g., Zygomaticus Major).

Trial Registry: N=1,200 Multi-Center Study

• 98.5% Patient Safety Satisfaction Rate

• <1% Incidence of Ptosis or Localized Edema

• 85% Efficacy in Axillary Hyperhidrosis Control

• 30% Masseteric Hypertrophy Reduction (90 Days)

STEP 01: DILUTION

Aseptically reconstitute with 1.0mL – 2.5mL of 0.9% Preservative-Free Sodium Chloride. Do not agitate; swirl gently to avoid foaming.

STEP 02: INJECTION

Utilize 30G ultra-fine. Intramuscular delivery. Cosmetic dosing: 4U-50U per region. Medical dosing: Up to 100U.

STEP 03: STORAGE

Maintain unopened at -5℃ to 3℃. Use within 24 hours post-reconstitution for maximum potency (refrigerated at 2-8℃).

Packaging & Integrity

• Unit Content: 200U Lyophilized Powder / Single-Use

• Shelf Life: 24 Months from manufacturing date

• Cold Chain: Shipped via temperature-controlled logistics (-5℃±3℃)

• Tracking: Unique Lot Number and QR Code for authenticity verification

Contraindications

Strictly prohibited for individuals with neuromuscular disorders (Myasthenia Gravis, Lambert-Eaton Syndrome), pregnancy, or lactation. Do not combine with aminoglycoside antibiotics.